TMX Newsfile

IN THE PRESS

ScreenPro Reports a Major Increase in Positive Test Results

October 28, 2022

·

5 min read

Genetown

Neurocast Unveils Neurokeys Platform To Monitor Brain Health Anytime, Anywhere, Effortlessly With Just Your SmartPhone

October 27, 2022

·

2 min read

Pharm Country

Adaptimmune to Report Q3 2022 Financial and Business Updates on Tuesday, November 8, 2022

October 27, 2022

·

2 min read

BioMark’s Glioblastoma Study Published in Cancers Demonstrates Inhibiting SAT1 Sensitized Cancer Cells Towards Radiation and Chemotherapy

October 27, 2022

·

3 min read

Therma Bright Receives New Billing Codes for Venowave Allowing for Reimbursement from Medicare, Medicaid, and Private Insurers

October 27, 2022

·

6 min read

Hemostemix Announces Dr. Giannetti and Dr. Cecere as Co-Lead Medical Consultants, Cardiovascular Clinical Trials

October 26, 2022

·

7 min read

Marvel Biosciences Advances Closer to Human Trials After the Successful Completion of a Second Maximum Tolerated Dose Study, a Critical Milestone Towards FDA Clinical Studies

October 25, 2022

·

4 min read

BioHarvest Introduces its 1st Cannabis Breakthrough Composition with Major Medical and Commercial Implications

October 25, 2022

·

7 min read

Adaptimmune Enhances Its Pipeline of Wholly Owned Cell Therapies for Cancer with Transfer of PRAME and NY-ESO Target Programs from GSK

October 25, 2022

·

3 min read

Izotropic’s IzoView Is Weeks Away from Final Engineering & Showcasing to Investment and Scientific Communities

October 25, 2022

·

6 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750